2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Molecular Therapy Oncology MOL THER ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 0.0
50人评分
我要评分
声誉 0.0 影响力 0.0 速度 0.0 | |||||||||||||||||||||||||||||
| 期刊ISSN | 2950-3299 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||||||
| 实时影响因子 | - | |||||||||||||||||||||||||||||
| 2025-2026自引率 | 2.4%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 32.196数据由网友[喜欢猫青年]收集提供 | |||||||||||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||
| 期刊官方网站 | ||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4+T cells to inhibit systemic microbial infection Author: Yue, Shuai; He, Junjian; Ye, Shusen; Lin, Yao; Yang, Yang; Hao, Yaxing; Liang, Texi; Qiu, Ding; Li, Kaiyi; Xie, Chunyang; Wang, Hairu; Xi, Wenwen; Yang, Xiaofan; Xiong, Yanli; Xu, Yu; Xu, Wenyue; Yang, Yi; Zhang, Guozhong; Zhao, Jing; Ye, Lilin; Li, Mengxia; Chen, Xiangyu Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201187 Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activity Author: Wang, Jiao; Sun, Yao; Starzyk, Jakob; Wang, Fei; Dong, Xin; Shan, Richard; He, Xuemei; Xie, Keqiang; Xie, Guozhu; Wu, Hao Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201206 NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach Author: Chen, Yuchen; Jiang, Zuoyu; Jin, Sen; Liu, Meng; Chen, Ming; Kuo, Tsang-Chih; Zhou, Kai; Pu, Liting; Chen, Shiyuan; Li, Xuetao; Chen, Adalia S.; Xie, Jingmu; Zhang, Huitao; Wang, Qingsong; Xu, Jie; Sheng, Jian; Huang, Yulun; Chen, Gong Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201205 Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype Author: Xu, Haoran; Wan, Marcus Chun Tao; Wong, Chelsey Chi Ching; Qin, Siqi; Wen, Yang; Wang, Jun; Chen, Zhiwei Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201221 | |||||||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Molecular Therapy Oncology的语言要求，还能让Molecular Therapy Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Molecular Therapy Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||
| 通讯方式 | ||||||||||||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||||||||||
| 涉及的研究方向 | Multiple- | |||||||||||||||||||||||||||||
| 出版国家或地区 | ||||||||||||||||||||||||||||||
| 出版语言 | ||||||||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||||||
| 年文章数 | 135点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 86.67% | |||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） | （没有被2025年的期刊分区表收录，仅供参考） | |||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） | （没有被旧的期刊分区表收录，仅供参考） | |||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2950-3299%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Molecular Therapy Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4+T cells to inhibit systemic microbial infection Author: Yue, Shuai; He, Junjian; Ye, Shusen; Lin, Yao; Yang, Yang; Hao, Yaxing; Liang, Texi; Qiu, Ding; Li, Kaiyi; Xie, Chunyang; Wang, Hairu; Xi, Wenwen; Yang, Xiaofan; Xiong, Yanli; Xu, Yu; Xu, Wenyue; Yang, Yi; Zhang, Guozhong; Zhao, Jing; Ye, Lilin; Li, Mengxia; Chen, Xiangyu Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201187 PubMed DOI |
| 2. | Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activity Author: Wang, Jiao; Sun, Yao; Starzyk, Jakob; Wang, Fei; Dong, Xin; Shan, Richard; He, Xuemei; Xie, Keqiang; Xie, Guozhu; Wu, Hao Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201206 PubMed DOI |
| 3. | NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach Author: Chen, Yuchen; Jiang, Zuoyu; Jin, Sen; Liu, Meng; Chen, Ming; Kuo, Tsang-Chih; Zhou, Kai; Pu, Liting; Chen, Shiyuan; Li, Xuetao; Chen, Adalia S.; Xie, Jingmu; Zhang, Huitao; Wang, Qingsong; Xu, Jie; Sheng, Jian; Huang, Yulun; Chen, Gong Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201205 PubMed DOI |
| 4. | Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype Author: Xu, Haoran; Wan, Marcus Chun Tao; Wong, Chelsey Chi Ching; Qin, Siqi; Wen, Yang; Wang, Jun; Chen, Zhiwei Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201221 PubMed DOI |
| 5. | Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential Author: Liao, Rui; Chan, Cecilia Ka Wing; Cui, Yuanbin; Li, Shanglin; Ma, Ruiying; Peng, Dongdong; Mei, Piaorong; Xu, Mingjing; Li, Peng; Wong, Nathalie Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201181 PubMed DOI |
| 6. | Engineered Salmonela-mediated c-di-AMP delivery activates STING to remodel the tumor microenvironment Author: Huang, Yuanjia; Piao, Linghua; Zhang, Haiwen; Liu, Xiande Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201185 PubMed DOI |
| 7. | CBX6 and CA9 as predictive indicators and therapeutic targets in GBM Author: Wang, Yujun; Jia, Yongsheng; Yuan, Yate-Ching; Li, Gang; Wang, Jinhui; Chen, Mike Yue; Feldman, Lisa Anne Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 2, pp. -. DOI: 10.1016/j.omton.2026.201159 PubMed DOI |
| 8. | A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity Author: Heinze, Sabine; Stadler, Giovanna L.; Zhang, Yonghui; Engeland, Christine E.; Barth, Thomas F. E.; Heidbuechel, Johannes P. W.; Meyer, Li Der H.; Muhlebach, Michael D.; Debatin, Klaus-Michael; Dorneburg, Carmen; Beltinger, Christian Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 1, pp. -. DOI: 10.1016/j.omton.2026.201127 PubMed DOI |
| 9. | The emerging role of aptamers in targeted cancer immunotherapy Author: Zhu, Sai; Xu, Ruiling; Xu, Haodong; Wang, Yu; Wang, Lu; He, Na; Wang, Hong-Hui; Ren, Xiaolei Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 1, pp. -. DOI: 10.1016/j.omton.2025.201110 PubMed DOI |
| 10. | Suppression of PARP1 enhances PTEN mRNA therapy in castration-resistant prostate cancer by glycolysis disruption Author: Hu, Bo; Wu, Pengfei; Zheng, Lulu; Yang, Haiyin; Fan, Yuchuan; Yang, Jun; Tang, Lu; Kong, Sudong; Zhu, Chao; Yang, Minghui; Zhang, Jiatao; Liu, Qing; Huang, Yuanyu Journal: MOLECULAR THERAPY ONCOLOGY. 2026; Vol. 34, Issue 1, pp. -. DOI: 10.1016/j.omton.2026.201133 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共0条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
